Form 8-K - Current report:
SEC Accession No. 0001213900-25-061364
Filing Date
2025-07-03
Accepted
2025-07-03 13:30:30
Documents
12
Period of Report
2025-06-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0248143-8k_pluri.htm   iXBRL 8-K 47308
  Complete submission text file 0001213900-25-061364.txt   215968

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE plur-20250630.xsd EX-101.SCH 3029
3 XBRL LABEL FILE plur-20250630_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE plur-20250630_pre.xml EX-101.PRE 22368
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0248143-8k_pluri_htm.xml XML 3680
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 251104832
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)